Fenologica

Fenologica

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $4.5M

Overview

Fenologica is a private, pre-revenue platform company developing an integrated instrumentation and cloud-based software solution for high-throughput functional cell analysis. Its technology, born from a collaboration with the Pacific Northwest Research Institute (PNRI) and the Dudley Lab, uses continuous multispectral imaging and AI-driven analytics to analyze thousands of microbial samples in situ, reducing experiment time by 10x and cost by 95% compared to legacy methods. The platform addresses a critical bottleneck in synthetic biology and functional genomics by providing rich kinetic and phenotypic data, enabling researchers to understand how genotype influences phenotype. Its initial market is academic and industrial microbiology labs, with long-term applications in pharmaceutical discovery, agriculture, and environmental science.

Digital HealthAI / Machine LearningDiagnostics

Technology Platform

Integrated hardware-software-cloud platform for high-throughput, in-situ, multispectral imaging and AI-driven analysis of functional cell assays, initially focused on microbial samples.

Funding History

1
Total raised:$4.5M
Seed$4.5M

Opportunities

The platform addresses a major bottleneck in synthetic biology and functional genomics, enabling 10x faster and 95% cheaper analysis.
This creates a large market opportunity across academic research, industrial biotech (biofuels, agriculture), and pharmaceutical R&D.
The cloud-based, data-rich approach positions the company to become a central informatics hub for phenotypic data.

Risk Factors

The company faces significant technical integration risks in combining hardware, software, and cloud services.
As a pre-revenue startup, it is dependent on securing additional funding to reach commercialization.
It must also overcome market inertia and convince labs to adopt a novel, unproven platform over established methods.

Competitive Landscape

Fenologica competes with established life science tool companies offering high-content screening systems (e.g., PerkinElmer, Thermo Fisher) and a growing field of startups focused on lab automation and AI-driven image analysis. Its differentiation lies in the specific application to continuous, in-situ imaging of solid microbial assays at very high density, a niche not fully addressed by generic plate readers or imagers.